White House Office of Management and Budget review on Cannabis-Derived Products confirms Rapid Therapeutic Science Laboratories’ Long-Term Strategy

DALLAS, March 21, 2023 (GLOBE NEWSWIRE) — Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic” or the “Company”), a growth-oriented aerosol manufacturing company focused on natu…